Patent of key input to expire on March 20, pharma companies ready with generic versions ...

It’s been a topsy-turvy week for Novo Nordisk, makers of the popular weight loss drugs Ozempic and Wegovy. Fresh off the heels of a disappointing trial for one experimental drug, the company has just ...

Drugmaker Novo Nordisk plans to slash list prices for its wildly popular weight-loss and diabetes drugs Wegovy and Ozempic by ...

Novo Nordisk will cut prices of the diabetes and weight loss drugs Ozempic, Rybelsus and Wegovy to $675 effective Jan. 1, ...

These patients, who may have high-deductible health plans or co-insurance, will be able to purchase both the pill and injection forms of obesity treatment Wegovy, the Ozempic diabetes shot, and oral ...

Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, ...

The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss ...

The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of ...

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.

The reductions will take effect next January, and both Ozempic and Wegovy will list for $675 a month.

The healthcare company said all doses will shift to a single monthly list price, cutting Wegovy’s price by about 50% and ...